日水製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|---|---|---|
東証PRM | 医薬品 | 4550/E00971 | Nissui Pharmaceutical Co., Ltd |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|---|---|---|---|---|---|---|---|---|
2013/08/09 | 日証協 | 24,500株 | -6.13% | 42,300株 | -12.6% | 65,538株 | +2.82% | 3,800株 | +52% |
2013/08/02 | 日証協 | 26,100株 | -11.82% | 48,400株 | -34.51% | 63,738株 | -2.3% | 2,500株 | -3.85% |
2013/07/26 | 日証協 | 29,600株 | +14.29% | 73,900株 | +122.59% | 65,238株 | -1.06% | 2,600株 | +420% |
2013/07/19 | 日証協 | 25,900株 | -17.78% | 33,200株 | -41.65% | 65,938株 | -6.39% | 500株 | -80.77% |
2013/07/12 | 日証協 | 31,500株 | -8.7% | 56,900株 | +16.36% | 70,438株 | -8.09% | 2,600株 | -43.48% |
2013/07/05 | 日証協 | 34,500株 | +2.07% | 48,900株 | +72.79% | 76,638株 | -0.39% | 4,600株 | +318.18% |
2013/06/28 | 日証協 | 33,800株 | -13.11% | 28,300株 | -50.44% | 76,939株 | -2.53% | 1,100株 | -88.78% |
2013/06/21 | 日証協 | 38,900株 | 0% | 57,100株 | -37.66% | 78,939株 | +5.48% | 9,800株 | -9.26% |
2013/06/14 | 日証協 | 38,900株 | -4.42% | 91,600株 | -20.83% | 74,839株 | +5.05% | 10,800株 | -22.3% |
2013/06/07 | 日証協 | 40,700株 | -23.78% | 115,700株 | +65.7% | 71,239株 | 0% | 13,900株 | +152.64% |
2013/05/31 | 日証協 | 53,400株 | +16.91% | 69,823株 | -40.47% | 71,240株 | +7.55% | 5,502株 | -38.87% |
2013/05/24 | 日証協 | 45,677株 | -6.55% | 117,300株 | -41.39% | 66,238株 | -0.6% | 9,000株 | -53.85% |
2013/05/17 | 日証協 | 48,877株 | -13.34% | 200,131株 | +10.96% | 66,638株 | +3.58% | 19,500株 | +323.64% |
2013/05/10 | 日証協 | 56,400株 | +16.29% | 180,370株 | +47.84% | 64,335株 | -3.31% | 4,603株 | +142.26% |
2013/05/02 | 日証協 | 48,500株 | -2.22% | 122,000株 | -26.9% | 66,535株 | -0.51% | 1,900株 | -24.45% |
2013/04/26 | 日証協 | 49,600株 | -3.31% | 166,900株 | -5.12% | 66,873株 | -3.58% | 2,515株 | -6.85% |
2013/04/19 | 日証協 | 51,300株 | +2.19% | 175,900株 | -13.82% | 69,359株 | +3.58% | 2,700株 | +8% |
2013/04/12 | 日証協 | 50,200株 | +7.26% | 204,100株 | +365.98% | 66,959株 | -36.2% | 2,500株 | -37.62% |
2013/04/05 | 日証協 | 46,800株 | -5.84% | 43,800株 | +415.29% | 104,954株 | +36.61% | 4,008株 | -92.77% |
※株式分割は考慮していませんのでご注意ください。